Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Aug;32(8):1107–1112. doi: 10.1128/aac.32.8.1107

Mechanisms of antibiotic resistance in Campylobacter species.

D E Taylor 1, P Courvalin 1
PMCID: PMC172360  PMID: 3056250

Full text

PDF
1107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradbury W. C., Munroe D. L. Occurrence of plasmids and antibiotic resistance among Campylobacter jejuni and Campylobacter coli isolated from healthy and diarrheic animals. J Clin Microbiol. 1985 Sep;22(3):339–346. doi: 10.1128/jcm.22.3.339-346.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brunton W. A., Wilson A. M., Macrae R. M. Erythromycin-resistant campylobacters. Lancet. 1978 Dec 23;2(8104-5):1385–1385. doi: 10.1016/s0140-6736(78)92027-5. [DOI] [PubMed] [Google Scholar]
  3. Burdett V., Inamine J., Rajagopalan S. Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol. 1982 Mar;149(3):995–1004. doi: 10.1128/jb.149.3.995-1004.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burdett V. Streptococcal tetracycline resistance mediated at the level of protein synthesis. J Bacteriol. 1986 Feb;165(2):564–569. doi: 10.1128/jb.165.2.564-569.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burridge R., Warren C., Phillips I. Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli. J Antimicrob Chemother. 1986 Mar;17(3):315–321. doi: 10.1093/jac/17.3.315. [DOI] [PubMed] [Google Scholar]
  6. Butzler J. P., Skirrow M. B. Campylobacter enteritis. Clin Gastroenterol. 1979 Sep;8(3):737–765. [PubMed] [Google Scholar]
  7. Dooley C. P., Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med. 1988 Jan;108(1):70–79. doi: 10.7326/0003-4819-108-1-70. [DOI] [PubMed] [Google Scholar]
  8. Eliopoulos G. M., Gardella A., Moellering R. C., Jr In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent. Antimicrob Agents Chemother. 1984 Mar;25(3):331–335. doi: 10.1128/aac.25.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flores B. M., Fennell C. L., Holmes K. K., Stamm W. E. In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother. 1985 Aug;28(2):188–191. doi: 10.1128/aac.28.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gebhart C. J., Edmonds P., Ward G. E., Kurtz H. J., Brenner D. J. "Campylobacter hyointestinalis" sp. nov.: a new species of Campylobacter found in the intestines of pigs and other animals. J Clin Microbiol. 1985 May;21(5):715–720. doi: 10.1128/jcm.21.5.715-720.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goodman L. J., Fliegelman R. M., Trenholme G. M., Kaplan R. L. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother. 1984 Apr;25(4):504–506. doi: 10.1128/aac.25.4.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goossens H., De Mol P., Coignau H., Levy J., Grados O., Ghysels G., Innocent H., Butzler J. P. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother. 1985 Mar;27(3):388–392. doi: 10.1128/aac.27.3.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hächler H., Kayser F. H., Berger-Bächi B. Homology of a transferable tetracycline resistance determinant of Clostridium difficile with Streptococcus (Enterococcus) faecalis transposon Tn916. Antimicrob Agents Chemother. 1987 Jul;31(7):1033–1038. doi: 10.1128/aac.31.7.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Karmali M. A., De Grandis S., Fleming P. C. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother. 1981 Apr;19(4):593–597. doi: 10.1128/aac.19.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Karmali M. A., Penner J. L., Fleming P. C., Williams A., Hennessy J. N. The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three-year period. J Infect Dis. 1983 Feb;147(2):243–246. doi: 10.1093/infdis/147.2.243. [DOI] [PubMed] [Google Scholar]
  16. Kotarski S. F., Merriwether T. L., Tkalcevic G. T., Gemski P. Genetic studies of kanamycin resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 1986 Aug;30(2):225–230. doi: 10.1128/aac.30.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Labigne-Roussel A., Courvalin P. IS15, a new insertion sequence widely spread in R plasmids of gram-negative bacteria. Mol Gen Genet. 1983;189(1):102–112. doi: 10.1007/BF00326061. [DOI] [PubMed] [Google Scholar]
  18. Lambert T., Gerbaud G., Trieu-Cuot P., Courvalin P. Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol. 1985 Sep-Oct;136B(2):135–150. doi: 10.1016/s0769-2609(85)80040-5. [DOI] [PubMed] [Google Scholar]
  19. Manavathu E. K., Hiratsuka K., Taylor D. E. Nucleotide sequence analysis and expression of a tetracycline-resistance gene from Campylobacter jejuni. Gene. 1988;62(1):17–26. doi: 10.1016/0378-1119(88)90576-8. [DOI] [PubMed] [Google Scholar]
  20. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  21. Martin P., Trieu-Cuot P., Courvalin P. Nucleotide sequence of the tetM tetracycline resistance determinant of the streptococcal conjugative shuttle transposon Tn1545. Nucleic Acids Res. 1986 Sep 11;14(17):7047–7058. doi: 10.1093/nar/14.17.7047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Michel J., Rogol M., Dickman D. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother. 1983 May;23(5):796–797. doi: 10.1128/aac.23.5.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Morse S. A., Johnson S. R., Biddle J. W., Roberts M. C. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother. 1986 Nov;30(5):664–670. doi: 10.1128/aac.30.5.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Oka A., Sugisaki H., Takanami M. Nucleotide sequence of the kanamycin resistance transposon Tn903. J Mol Biol. 1981 Apr 5;147(2):217–226. doi: 10.1016/0022-2836(81)90438-1. [DOI] [PubMed] [Google Scholar]
  25. Ouellette M., Gerbaud G., Lambert T., Courvalin P. Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1987 Jul;31(7):1021–1026. doi: 10.1128/aac.31.7.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rivera M. J., Castillo J., Martin C., Navarro M., Gomez-Lus R. Aminoglycoside-phosphotransferases APH(3')-IV and APH(3") synthesized by a strain of Campylobacter coli. J Antimicrob Chemother. 1986 Aug;18(2):153–158. doi: 10.1093/jac/18.2.153. [DOI] [PubMed] [Google Scholar]
  27. Roberts M. C., Hillier S. L., Hale J., Holmes K. K., Kenny G. E. Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother. 1986 Nov;30(5):810–812. doi: 10.1128/aac.30.5.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Roberts M. C., Kenny G. E. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother. 1986 Feb;29(2):350–352. doi: 10.1128/aac.29.2.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Roberts M. C., Koutsky L. A., Holmes K. K., LeBlanc D. J., Kenny G. E. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother. 1985 Jul;28(1):141–143. doi: 10.1128/aac.28.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sagara H., Mochizuki A., Okamura N., Nakaya R. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother. 1987 May;31(5):713–719. doi: 10.1128/aac.31.5.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Shungu D. L., Nalin D. R., Gilman R. H., Gadebusch H. H., Cerami A. T., Gill C., Weissberger B. Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents. Antimicrob Agents Chemother. 1987 Jun;31(6):949–950. doi: 10.1128/aac.31.6.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Simor A. E., Wilcox L. Enteritis associated with Campylobacter laridis. J Clin Microbiol. 1987 Jan;25(1):10–12. doi: 10.1128/jcm.25.1.10-12.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tauxe R. V., Patton C. M., Edmonds P., Barrett T. J., Brenner D. J., Blake P. A. Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol. 1985 Feb;21(2):222–225. doi: 10.1128/jcm.21.2.222-225.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Taylor D. E., Chang N., Garner R. S., Sherburne R., Mueller L. Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada. Can J Microbiol. 1986 Jan;32(1):28–32. doi: 10.1139/m86-006. [DOI] [PubMed] [Google Scholar]
  35. Taylor D. E., De Grandis S. A., Karmali M. A., Fleming P. C. Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother. 1981 May;19(5):831–835. doi: 10.1128/aac.19.5.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Taylor D. E., Garner R. S., Allan B. J. Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 1983 Dec;24(6):930–935. doi: 10.1128/aac.24.6.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Taylor D. E., Hargreaves J. A., Ng L. K., Sherbaniuk R. W., Jewell L. D. Isolation and characterization of Campylobacter pyloridis from gastric biopsies. Am J Clin Pathol. 1987 Jan;87(1):49–54. doi: 10.1093/ajcp/87.1.49. [DOI] [PubMed] [Google Scholar]
  38. Taylor D. E., Hiratsuka K., Ray H., Manavathu E. K. Characterization and expression of a cloned tetracycline resistance determinant from Campylobacter jejuni plasmid pUA466. J Bacteriol. 1987 Jul;169(7):2984–2989. doi: 10.1128/jb.169.7.2984-2989.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Taylor D. E., Ng L. K., Lior H. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother. 1985 Nov;28(5):708–710. doi: 10.1128/aac.28.5.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Taylor D. E. Plasmid-mediated tetracycline resistance in Campylobacter jejuni: expression in Escherichia coli and identification of homology with streptococcal class M determinant. J Bacteriol. 1986 Mar;165(3):1037–1039. doi: 10.1128/jb.165.3.1037-1039.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Taylor D. N., Blaser M. J., Echeverria P., Pitarangsi C., Bodhidatta L., Wang W. L. Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother. 1987 Mar;31(3):438–442. doi: 10.1128/aac.31.3.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tenover F. C., Bronsdon M. A., Gordon K. P., Plorde J. J. Isolation of plasmids encoding tetracycline resistance from Campylobacter jejuni strains isolated from simians. Antimicrob Agents Chemother. 1983 Feb;23(2):320–322. doi: 10.1128/aac.23.2.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tenover F. C., LeBlanc D. J., Elvrum P. Cloning and expression of a tetracycline resistance determinant from Campylobacter jejuni in Escherichia coli. Antimicrob Agents Chemother. 1987 Sep;31(9):1301–1306. doi: 10.1128/aac.31.9.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tenover F. C., Williams S., Gordon K. P., Nolan C., Plorde J. J. Survey of plasmids and resistance factors in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 1985 Jan;27(1):37–41. doi: 10.1128/aac.27.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Totten P. A., Fennell C. L., Tenover F. C., Wezenberg J. M., Perine P. L., Stamm W. E., Holmes K. K. Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis. 1985 Jan;151(1):131–139. doi: 10.1093/infdis/151.1.131. [DOI] [PubMed] [Google Scholar]
  46. Trieu-Cuot P., Gerbaud G., Lambert T., Courvalin P. In vivo transfer of genetic information between gram-positive and gram-negative bacteria. EMBO J. 1985 Dec 16;4(13A):3583–3587. doi: 10.1002/j.1460-2075.1985.tb04120.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Walder M. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother. 1979 Jul;16(1):37–39. doi: 10.1128/aac.16.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weisblum B. Inducible erythromycin resistance in bacteria. Br Med Bull. 1984 Jan;40(1):47–53. doi: 10.1093/oxfordjournals.bmb.a071947. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES